Research Manitoba and Boehringer Ingelheim Canada Partnership to Invest in Diabetes Care in Indigenous Populations in Manitoba
November 30, 2020 - Winnipeg Manitoba. Research Manitoba and Boehringer Ingelheim (Canada) Ltd. are excited to announce a new partnership, with the creation of the Boehringer Ingelheim-Research Manitoba (BI-RM) Partnership Fund. The fund will support community-based research and innovation projects focused on improving diabetes health outcomes within Indigenous communities in Manitoba.
Support from the BI-RM Partnership Fund will align with the province of Manitoba’s Shared Health Clinical and Preventative Services Plan, and Boehringer Ingelheim Canada’s PATHWAYS – Indigenous Health Collaborations, a partnership established with Bimaadzwin intended to empower Indigenous communities in improving health and wellness.
“We are very excited about entering into this collaboration with our renowned partner, Boehringer Ingelheim Canada, to provide support for Indigenous-led projects to improve health systems and patient care in their communities,” said Sean McKay, Interim CEO, Research Manitoba. “This is the second of what we anticipate to be many collaborations through Research Manitoba’s recently launched Strategic Partnerships Program that aims to leverage relationships and funding to significantly increase the amount of research carried out in Manitoba for the benefit of the community at large.”
Research Manitoba Announces Strategic Partnership and Funding for Health Research Innovation in Manitoba
September 24, 2020 – Winnipeg, Manitoba. Honourable Ralph Eichler, Minister of Economic Development and Training, launched Research Manitoba’s first Strategic Partnership with the Victoria General Hospital Foundation (VGHF). Today the partners announced $470,000 in research funding to support a health research competition to begin in the Fall of 2020 ($110,000) and a research study, which uses telepresence robots to remotely interact between persons with dementia (PWD) and their caregivers to extend stay at home care opportunities ($360,000).
“Our province is committed to ensuring that our research and innovation investments are aligned with industry need and health care priorities,” said Ralph Eichler, Minister of Economic Development and Training. “This partnership will lay the groundwork for meaningful health and economic outcomes, while improving the health and well-being of all Manitobans.”
This strategic partnership is a model for other partnerships, bringing together industry and research, supporting innovation in Manitoba. The Strategic Partnership Program engages with new sectors of industry, builds collaborations that create economic growth, provides employment opportunities, and supports local talent.
Research Manitoba Funds COVID-19 Rapid Response Grants and Clinical Trials in Manitoba
September 4, 2020 – Winnipeg, Manitoba. Today Research Manitoba announced $3.8M in research funding to support the recipients of the Manitoba COVID-19 Rapid Response Grant Competition and eight Manitoba clinical trials related to COVID-19 and applied health research. This funding has leveraged a further $5.6M from our partners to provide a total of $9.4M to support this essential work.
“Our government is committed to keeping Manitobans healthy and safe, especially as we navigate the current global pandemic. Manitoba is home to a highly-skilled, world-class research community who are on the front lines of the fight against COVID-19. This funding partnership with Research Manitoba will provide substantial financial support for cutting-edge research and clinical trials to address the effects of this virus.” - Hon. Cameron Friesen, Minister of Health, Seniors and Active Living.
“Earlier this year the Province of Manitoba provided Research Manitoba with an opportunity to support clinical trials and applied health research related to COVID-19” said Sean McKay, Interim CEO, Research Manitoba. “As a result, we immediately stimulated strong partnerships and provided funding opportunities for our world class Manitoba-based research teams to participate in the global response. It is heartening to see how our provincial government, researcher and stakeholder communities have so rapidly come together to support this crucial research.”
Supporting Local Talent and Research Excellence in Manitoba
August 28, 2020 – Today Research Manitoba and partners announced $1,182,361 in research funding to support 30 Master’s Studentships, two PhD Studentships, two Postdoctoral Fellowships, and seven New Investigator Operating Grants in Manitoba in health, social sciences and humanities, and natural sciences and engineering.
The recipients of the 2020 Grants and Awards Competition are highly qualified trainees and new investigators in health, natural sciences and engineering, and social sciences and humanities in Manitoba. The Grants and Awards prepare recipients for careers as independent researchers in industry or within Manitoba’s research enterprise and help to establish independent research programs and achieve the research productivity necessary to compete on a national level.
Research Manitoba Announces Appointment of Interim CEO
Wednesday, August 19, 2020 - Research Manitoba announces today the appointment of Mr. Sean McKay, as Interim Chief Executive Officer.
“Mr. McKay is an experienced professional who brings a broad range of skills acquired through his leadership positions in a variety of industry and research settings and will make an excellent addition to the team,” said Ms. Tracey Maconachie, Research Manitoba Board Chair. “All of us at Research Manitoba look forward to working with Sean as we continue to support the provincial research enterprise.”
“I am looking forward to applying my experience and network connections to support Research Manitoba during this transitional period and especially excited to be involved in the introduction of new programs advancing leading edge research in Manitoba and the implementation of the Research Improvements Through Harmonization In Manitoba (RITHIM) initiative.” Mr. Sean McKay, Interim CEO, Research Manitoba.
Manitoba Companies Receive Funding for COVID-19 Innovation Proof-of-Concept Grants
August 11, 2020 – Winnipeg, Manitoba
Today Research Manitoba is pleased to announce a $250,000 investment to support two COVID-19 Innovation Proof-of-Concept (IPoC) Grants to local companies Adva Diagnostics Inc. and Cubresa Inc. These grants will support innovative research projects from these Manitoba-based companies who have the expertise to help fight the COVID-19 pandemic.
Adva Diagnostic Inc., a venture of InnovoXL, received $150,000 for their project to develop new on the spot tests for COVID-19 and other infectious diseases, which can help us safely return to work and more normal lives. Adva will provide $33,750 in-kind toward their IPoC Grant with an additional $112,500 from Mitacs.
Cubresa Inc. received $100,000, which builds on their expertise in creating new imaging tools, making them safe to use with highly infectious diseases like SARS COV-2. This is a critical step to understanding and developing new treatments for the disease. Cubresa will provide $36,500 in-kind toward their IPoC Grant.
Manitoba’s First Indigenous Research Chair in Nursing
Mentoring the Next Generation of Nursing Leaders
June 25, 2020 – Winnipeg, Manitoba
Today Research Manitoba announced $258,500 in research funding to support Manitoba’s first Indigenous Research Chair in Nursing: Wanda Phillips-Beck, Seven Generations Scholar, RN, MSc, PhD(c) and the project titled ‘Mentoring Nurse Leaders and Researchers in Indigenous Health Grounded in Culturally and Equity Informed Approaches to Research and Education’.
Ms. Wanda Phillips-Beck is associated with the First Nations Health and Social Secretariat of Manitoba (FNHSSM) and the project is supported in partnership with the Canadian Institutes of Health Research (CIHR), and the Canadian Nurses Foundation (CNF). Together the investment totals $985,000:
- Research Manitoba: $258,500
- CIHR: $699,500
- CNF: $27,000
$5-MILLION FUND FOR RESEARCH PROJECTS RELATED TO COVID-19
April 8, 2020 - New Fund to Advance Strides Toward Vaccines and Treatments for Coronavirus
A new, $5-million COVID-19 research fund through Research Manitoba was announced today by Health, Seniors and Active Living Minister Cameron Friesen.
“This new fund will support a clinical trial to determine if a commonly used drug can safely be used as a treatment for COVID-19,” said Friesen. “The fund will also provide support for local researchers to develop solutions to health-care issues in response to the COVID-19 pandemic.”
In February, following a recommendation from Dr. Brent Roussin, chief provincial public health officer, the Canadian Institutes of Health Research, with numerous partners, launched a funding opportunity for 10 clinical research professionals to test therapies to mitigate the rapid spread of COVID-19.
“This virus is one of the most serious public health emergencies the world has faced in many years,” said Roussin. “This fund will ensure important research can take place to help fight this virus and develop new ways to identify and treat patients, as well as develop strong partnerships to move this work forward.”
“We are proud to partner with Research Manitoba on this important work,” said Economic Development and Training Minister Ralph Eichler. “Agile and innovative thinking is what we need in rapidly evolving times such as these, and investments into research and development will help advance our understanding and ability to treat COVID-19.”
Local clinical and scientific researchers and senior officials from the Manitoba government, Shared Health and the Winnipeg Regional Health Authority (WRHA) have identified several new research projects. These include projects to test possible treatments in clinical trials, better understand how the disease is developing in Manitoba and better understand how the health system needs to react to different complications that are emerging around the world.
“We are pleased to refocus our research efforts on vital clinical trials and potential interventions in the fight against COVID-19,” said Tracey Maconachie, chair, Research Manitoba. “Our world-renowned partners are conducting leading-edge research that could expedite treatments for Manitobans and all Canadians.”
More than $3.5 million will be used to support clinical and applied research including $700,000 for Manitoba’s first COVID-19 clinical trial for a drug to fight this virus, the minister said. The study will test whether or not the drug hydroxychloroquine, used to treat rheumatology issues, can prevent people from contracting COVID-19. The scientific trial will determine if the drug can safely be used as a treatment for COVID-19.
“We are building on the work of preliminary studies to look at how this drug could help fight the spread of COVID-19,” said Dr. Ryan Zarychanski, associate professor, department of internal medicine, Max Rady College of Medicine, University of Manitoba and department of medical oncology and hematology, CancerCare Manitoba. “We are asking Manitobans who meet the study’s criteria to consider joining this trial to help us scientifically prove the benefits for Manitobans and people around the world.”
An additional $500,000 will be invested in partnerships with industry and philanthropic sources supporting existing trials based in Manitoba but with sites across Canada and in seven other countries around the world, Friesen said, adding $1 million will be invested in COVID-19 innovation projects including looking at the development of diagnostic tools.
“While we have learned a great deal about this virus in just a few months, there are many more questions that need to be answered,” said Friesen. “These investments will help contribute to the world’s understanding of the virus and make important strides toward vaccines, treatments and possible changes to our health system to better combat COVID-19.”
Manitobans who wish to participate in the clinical trial can visit www.covid-19research.ca for additional details.
For more information on COVID-19, visit www.manitoba.ca/covid19.
A comprehensive list of Manitoba government COVID-19 measures can be found at https://manitoba.ca/bg/2020/04/covid19.html
Research Manitoba Funds Manitoba-led COVID-19 Research Projects
March 20, 2020 – Winnipeg, Manitoba
Today Research Manitoba announced that they are partnering with the Canadian Institutes of Health Research (CIHR) to invest $800,000 to support three research projects through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity. The researchers are:
- Adolf Ng - An Investigation on Epidemic Logistical Response and Planning: The Case of Novel Coronavirus (Covid-19) - $258,900 – fully funded by Research Manitoba
- Bradley Pickering, Development of field-deployable and point-of-need diagnostics for SARS-CoV-2 using CRISPR-based technology - $411,820 ($270,550 Research Manitoba and $140,270 CIHR)
- Xiao-Jian Yao, Development of a novel DC-targeting vaccine that targets COVID-19 spike protein to control COVID-19 infection - $597,128 ($270,550 Research Manitoba and $326,578 CIHR)
These are 3 of 16 projects supported by CIHR in Manitoba and of 96 projects across Canada that will focus on developing and implementing measures to rapidly detect, manage, and reduce the transmission of COVID-19.
“Investing in COVID-19 research is a global priority,” said Christina Weise, CEO of Research Manitoba. “We are pleased to support these three local teams, which are part of a worldwide scientific effort in response to the COVID-19 pandemic.”
2020 Research Manitoba/Rady Faculty of Health Sciences Graduate Entrance Scholarship
March 20, 2020
Research Manitoba and the University of Manitoba Rady Faculty of Health Sciences are pleased to announce the recipients of the 2020 Research Manitoba/Rady Faculty of Health Sciences Graduate Entrance Scholarship!
All applicants are welcome to log into their GMS account to check the status of their application. Comments from reviewers will be posted for early April.
If you require any technical support with the GMS please email firstname.lastname@example.org.
If you have any questions regarding your award please contact Dr. Hope Anderson, Vice-Dean Graduate Studies, Rady Faculty of Health Sciences at: email@example.com.
COVID-19 Update #1
Research Manitoba is actively monitoring the emerging and rapidly evolving COVID-19 situation. We are taking proactive measures to ensure that we maintain a safe environment for our staff, review committees, and stakeholders.
Visitors to Research Manitoba:
The organization is transitioning face-to-face meetings to virtual or teleconference formats until further notice. The new approach is a safeguard as Research Manitoba's ongoing business is important and meetings should continue.
Office Hours and Availability:
As of March 15, 2020 we are enabling employees to work from home to help slow the spread of the virus. Our employees will continue to be available during office hours Monday to Friday via their email and office phone numbers.
We will revisit this decision in early April. Should anything change, updates will be provided.
News and Information:
Our updates and news will be available at https://researchmanitoba.ca/about/news-releases/. You can also follow us on Twitter - @Research_MB.
Questions or Concerns:
If you have questions or concerns about our programs or funding please email us at firstname.lastname@example.org or visit the website. Our help desk hours are from 8:30 am to 4:30 pm Monday to Friday. We may take up to 24 hours to respond at this time.
We sincerely appreciate your patience and flexibility.
From all of us at Research Manitoba
COVID-19 - Travel Cancellations
March 12, 2020
Given the rapidly changing situation involving COVID-19, Research Manitoba recognizes that there may be an impact on researchers with plans to travel for meetings or other research-related activities.
Individuals may decide to cancel trips as a result of various considerations and factors such as cancelled conferences, travel advisories (including those from Health Canada and Global Affairs Canada), or personal choice due to health or other concerns.
Research Manitoba confirms that the reimbursement of non-refundable travel fees from our research funds is acceptable considering the impacts of COVID-19. This applies to the travel of both principal investigators and research personnel, when cancellation occurs as described above.
If you have any questions regarding this please contact email@example.com.
Mitacs Internships Create Emerging Opportunities for Industry in Manitoba
March 10, 2020, Winnipeg, MB – Today, Research Manitoba and Mitacs announced the release of an Impact Report titled: Research Partnerships in Manitoba Leverage Innovation.
Research Manitoba collaborated with Mitacs to develop this report to describe the results and impacts of Manitoba-based research and communicate the impacts to a wide variety of audiences. Some of the key results published in the report include:
-Research Manitoba invested $850,000, which supported 221 internships — leveraging $5.7 million from industry and national partners in 2018–19 for research in Manitoba
-Investing in interns creates jobs in Manitoba
-The students developing unique skills and expertise enhance and strengthen Manitoba’s workforce
-Economic growth in Manitoba is created through the expansion of and innovations developed by Mitacs partner companies
$1 Million Investment in Prairie Research Kitchen
November 7, 2019
Investment in Red River College's Culinary Research Laboratory Supports Province's Dynamic Food Industry
The Manitoba government is investing $1 million through Research Manitoba in innovative culinary research at Red River College (RRC), Economic Development and Training Minister Ralph Eichler announced today.
“This investment helps further cutting-edge research in Manitoba’s agriculture and food industry, and bring new ideas and products to life,” said Eichler at the grand opening of RRC’s Prairie Research Kitchen. “Culinary research is an area of tremendous opportunity. The Prairie Research Kitchen provides a pathway to developing agri-food products that are not only good for our health, but are good for the Manitoba economy.”
The Prairie Research Kitchen at RRC’s Paterson GlobalFoods Institute will provide a dedicated workspace for culinary research and innovation that will serve Western Canada’s food production industry. The facility brings together food scientists, culinary arts and small-to-medium sized businesses to develop new products and teach culinary students food science skills.
Investing in Manitoba's Future
September 25, 2019
$1.24M Investment in research will support Master’s Students and Early Career Researchers
Research Manitoba announced today $1,293,295 in research funding to support 25 Master’s students and 12 early career researchers in Manitoba.
“By investing in these individuals, we are advancing our province’s world class research enterprise, growing Manitoba’s economy, and developing talent for today and tomorrow,” said Christina Weise, Chief Executive Officer at Research Manitoba. “Research is a driver of Manitoba’s prosperity and we would like to thank our partners who have been with us on this journey for the last several years.”
CancerCare Manitoba Foundation, Children’s Hospital Research Institute of Manitoba (CHRIM), Health Sciences Centre Foundation, and the Lung Association, Manitoba are providing an additional $100,950 in support of the 2019 Master’s Studentships.
Research Manitoba CEO, Ms Christina Weise, announcing $1.24 M in research funding for Master's students and early career researchers.
2018 John R. Evans Leaders Fund Awards
March 14, 2019
Funding our Future through Research Excellence
Research Manitoba announced today $1,151,730 in research funding for seven University of Manitoba projects supported through the John R. Evans Leaders Fund (JELF) of the Canada Foundation for Innovation (CFI). The Honourable Kirsty Duncan, Minister of Science and Sport, was in Winnipeg to announce matching federal funds and to celebrate the achievements of the Manitoba awardees.
Announcement - 2018 Trainee Awards
Research Competition Update:
Results for the 2018 Trainee Award Competition are now available.
Applicants can login to their GMS accounts to learn their score and whether they have been offered funding.
2018 GRANTS & AWARDS COMPETITION
May 3, 2018
The 2018 Grants and Awards Competition is now open.
MASTER’S TRAINEE PROGRAM:
• Application Deadline is FRIDAY, JUNE 8, 2018 (4:00PM CST)
• Referee letter deadline is Friday, June 22, 2018 (4:00PM CST)
There will be up to 11 awards will be awarded in each category (health, social sciences and the humanities, natural sciences and engineering)
• Awarded on a competitive basis and are valued at $12,000 annually
• Will begin on September 1st, 2018 for a 1-year period
• For more info please visit our webpage - Master's Studentships
NEW INVESTIGATOR PROGRAM:
• Application Deadline is TUESDAY, JULY 31, 2018 (4:00PM CST)
• Referee letter deadline is Tuesday, August 14, 2018 (4:00PM CST)
• $65,000 per year in the Health category
• $25,000 per year in the Natural Sciences and Engineering category
• $20,000 per year in the Social Sciences and Humanities category
• The amount of funds that may be used for equipment is limited to $10,000 (for small equipment), over the two years of the grant
• For more information please visit our webpage - New Investigator Operating Grants
Research Manitoba Announces Programs for 2018/19
April 30, 2018
We would like to thank the research community for being patient over the last year as Research Manitoba underwent a strategic planning process. The intent of the process was to provide our organization with a road map and establish a spectrum of funding programs that would bring the most impact to the Provincial research enterprise.
Research Manitoba’s strategic plan for 2018/19 to 2020/21 is the result of extensive engagement with our internal and external stakeholders and identifies areas of emphasis and critical issues that need to be addressed over the next three years. The plan sets out our high-level strategic goals for the next three years, which are: support the generation of research, impact policy and practice through knowledge translation, and strengthen capacity for research in Manitoba.
Research Manitoba - Budget
A Message from Ms. Christina Weise, Chief Executive Officer, Research Manitoba
March 14, 2018
Research Manitoba has a new annual budget of $12 million, which is a $3 million reduction from the 2017/18 fiscal year. We will continue to promote and support, and coordinate the funding of, research in the health, natural and social sciences, engineering and the humanities in Manitoba.
The Board of Directors and staff are in the final stages of an extensive strategic review of our activities. These efforts will help us to forge a new set of programs and organizational direction, which will be announced shortly.
We are committed to keeping our stakeholders and members of the research community informed throughout this process.
Please send all inquiries or questions to firstname.lastname@example.org.
Follow @ResearchMB on twitter for news and updates.
Click HERE for a PDF of the message.
SPOR - Networks in Chronic Disease
SPOR Network - Innovation in Pediatric Clinical Trials (IPCT) Project
PRESCRIBING THE RIGHT MEDICINE FOR CHILDREN
8.4 million in new research funding for national partnerships
June 16, 2017
Today, the University of Manitoba announced more than $8.4 million in new research funding provided by the Canadian Institutes of Health Research (CIHR), Research Manitoba, and the Children’s Hospital Foundation of Manitoba in partnership with other institutions across Canada.
Led by Dr. Terry Klassen in the Rady Faculty of Health Sciences at the University of Manitoba, the SPOR Network - Innovation in Pediatric Clinical Trials (IPCT) Project will use real patients under carefully controlled situations to measure how well a medication works and how safe it is. Knowledge gained from trials will help doctors choose which medicines to prescribe.
Click here to download the full release.
Photo from left to right:
Dr. Jay Doering, Associate Vice-President (Partnerships), University of Manitoba
Mr. Terry Duguid, Member of Parliament for Winnipeg South, and Parliamentary Secretary to the Minister of Status of Women
Dr. Terry Klassen, CEO and Scientific Director Children’s Hospital Research Institute of Manitoba; Professor and Head, Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba; Medical Director, Child Health Program, WRHA; and Academic Director, CHI
Dr. Brian Postl, Dean, Rady Faculty of Health Sciences & Vice-Provost (Health Sciences), University of Manitoba, and Chair, Research Manitoba
The Honourable Cliff Cullen, Minister of Growth, Enterprise and Trade, Province of Manitoba
Mr. Lawrence Prout, President and CEO, Children's Hospital Foundation of Manitoba Inc.
Research Manitoba - New Budget
April 13, 2017
A Message from Dr. Brian Postl, Chair of Research Manitoba Board of Directors:
Research Manitoba has a new annual budget of $15 million, which is a $2 million reduction from previous years. We will continue to promote and support, and coordinate the funding of, research in the health, natural and social sciences, engineering and the humanities in Manitoba.
The Board of Directors and staff are reviewing our budget and expected expenditures in the short term and will be undertaking a longer term strategic review of our activities. We are committed to keeping our stakeholders and members of the research community informed throughout this process.
Please send all inquiries or questions to email@example.com.
Follow @ResearchMB on twitter for news and updates.
MANITOBA AND GENOME CANADA INVEST IN RESEARCH IN CANADA’S ARCTIC - GENICE Project
$4 Million Investment for Genomics Research in Oil Spill Preparedness and Emergency Response in Arctic Marine Environment
Research Manitoba and The Government of Canada today announced $4 million in funding for GENICE: a large-scale applied research project (LSARP). LSARP is one of Genome Canada’s funding programs and is aimed at projects using genomic approaches to address challenges and opportunities of importance to Canada’s natural resources, including interactions between natural resources and the environment, thereby contributing to Canada’s bioeconomy and the well-being of Canadians.
(Photo from left to right)
Dr. Digvir Jayas, Vice-President (Research and International) and Distinguished Professor, University of Manitoba
Ms. Christina Weise, Chief Executive Officer, Research Manitoba
Dr. Simon Potter, Director of Operations, Genome Prairie
Dr. Gary Stern, Research Professor, Centre for Earth Observation Science (CEOS), University of Manitoba
Dr. Casey Hubert, Associate Professor, Department of Biological Sciences, University of Calgary
Ms. Sarah Guillemard, MLA for Fort Richmond
Terry Duguid, Parliamentary Secretary to the Minister of Families, Children and Social Development; Member of Parliament for Winnipeg South
$1.4M in Funding for MITACS
Research Manitoba and Mitacs announce funding to support innovation,
job creation, and skills development
December 2, 2015 - Today, Research Manitoba announced $1.4 million of funding to support research internships between researchers and local companies or not-for-profits.
Mitacs connects companies and not-for-profit organizations with local experts in the academic community to address their research and development challenges. These collaborations promote innovation in Manitoba.
Manitoba Dementia Research Chair
PROVINCE ANNOUNCES MORE MONEY FOR DEMENTIA RESEARCH IN MANITOBA
August 18, 2015 - More investments for research into dementia are being made through Research Manitoba and in partnership with the Alzheimer Society of Manitoba, Jobs and Economy Minister Kevin Chief announced today.
“With an aging population, there has never been a more important time to profile dementia research,” said Minister Chief. “We understand the contribution our seniors have made to this province and today’s announcement will put more resources in place so that we can better understand the best ways to treat and diagnose dementia.”
Today’s announcement recognizes Dr. Benedict Albensi as the recipient of the Manitoba Dementia Research Chair. Albensi is a professor in the department of pharmacology and therapeutics, faculty of health sciences, college of medicine, University of Manitoba and principal investigator, synaptic plasticity and cellular memory dysfunction in the neurodegenerative disorders division of St-Boniface Hospital Research Centre.
2014 Applied Health Services Research Recipients
January 6, 2015 - Research Manitoba is pleased to announce the 2014 Applied Health Services Research Grants. The funds that support Research Manitoba’s Applied Health Services Grants are provided through the Winnipeg Regional Health Authority.
Research Manitoba partnered with Manitoba Health, the regional health authorities, and the George and Fay Yee Centre for Healthcare Innovation (CHI) to support applied health services research. This focus area is important to the health system in Manitoba and supports collaborations between policy makers, service providers, and researchers interested in working together to address health system challenges.
Province Establishes Research Manitoba
The Manitoba government is establishing Research Manitoba, a new research funding organization that will bring existing research funding sources into a single, co-ordinated organization, under the chairmanship of Dr. Brian Postl, Jobs and the Economy Minister Theresa Oswald announced today.
National MS Clinical Trial Receives Approval, Patients Recruitment to Start by November 1
Halifax, September 28, 2012
The Honourable Leona Aglukkaq, Minister of Health, today announced that a national MS clinical trial has received the necessary medical and ethical approvals required to proceed. The clinical trial is a collaborative initiative between the Government of Canada, the provinces and territories and the MS Society of Canada.
MHRC PROVIDES UPDATE ON MS CLINICAL TRIALS
September 27, 2012
The Manitoba Health Research Council (MHRC) today provided an update on the national call for proposals for clinical trials for studying the treatments for CCSVI in Multiple Sclerosis (MS).